Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
You dial and inject
FDA Accepts Atara Biotherapeutics Resubmission of BLA for Tabelecleucel July 31, 2025 The FDA has accepted Atara Biotherapeutics' resubmission of a BLA for allogeneic Epstein-Barr virus (EBV)specific T-cell immunotherapy tabelecleucel (tab-cel
It is not FDA-approved and is not available by prescription in Hollywood, Miami, West Palm Beach, or anywhere in Florida outside of approved clinical trials
Safety Information and Possible Side Effects
GFR, glomerular filtrate rate
US$ 22.88
US$ 25.14
US$ 23.81
US$ 24.19
US$ 25.54
US$ 25.29
US$ 26.61
